CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 target
Drug / intervention
Prostate Health formulationdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02886832
NCT02886832N/ACompleted

A Pilot, Open-label Study to Evaluate the Effects of a Prostate Health Formulation on Scores Attained From the International Prostate Symptom Score (I-PSS) Questionnaire Among Overall Healthy Male Participants Who Report Lower Urinary Tract Complaints

Supplement Formulators, Inc.·interventional·Posted Sep 1, 2016·Updated Apr 18, 2018

In Brief

A clinical study evaluating Prostate Health formulation for Prostate Health. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study is to assess the efficacy of a Prostate Health formulation on scores attained from the I-PSS questionnaire. Safety and tolerability of the formulation will also be assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Health
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 1, 2016
Enrollment StartSep 21, 2016
Primary CompletionFeb 27, 2018
Study CompletionMar 27, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.8 years ago

Interventions

Prostate Health formulationdietary